Wednesday, May 31, 2023
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Debiopharm announces launch of galuci study for its Caix-Targeted radiopharmaceutical program

admin - 0
Latest Pharma-News

AZ’s Eplontersen shpows benefit for hereditary transthyretin-mediated amyloid polyneuropathy through 66 weeks

admin - 0
Latest Pharma-News

Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis for breast cancer

admin - 0
Latest Pharma-News

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

admin - 0
Latest Pharma-News

Sandoz receives US FDA approval for biosimilar Hyrimoz® high-concentration formulation

admin - 0
Latest Pharma-News

Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma

admin - 0
Latest Pharma-News

Bayer’s Nubeqa™ approved for additional prostate cancer indication in China

admin - 0
Latest Pharma-News

FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products

admin - 0
Latest Pharma-News

Pfizer’s XTANDI® plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer

admin - 0
Latest Pharma-News

FDA Denies Marketing of Two Vuse Solo Menthol E-Cigarette Products

admin - 0
Latest Pharma-News

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

admin - 0
Latest Pharma-News

FDA Authorizes Copenhagen Classic Snuff to be Marketed as a Modified Risk Tobacco Product

admin - 0
1234...143Page 3 of 143
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved